Home » 幹細胞專業新聞 » Prognosis E-News

Dr. Abidi has led a two-part Phase I dose escalation study that enrolled patients with multiple myeloma with normal and abnormal renal function. Multiple myeloma — cancer of the plasma cells — can cause kidney disease, … The drug Melphalan is the standard conditioning treatment that prepares patients for autologous stem cell transplantation. However, it brings with it symptoms that include severe mouth ulcers at doses of 200 milligrams per meter squared or higher, …
[Read more]

Comments are closed.

免費訂閱最新資訊

只需輸入閣下之電郵地址,我們便會向定時你發送本站最新新聞及相關資訊,費用全免。

聯絡我們

Name*

Email*

Tel

Message*

captcha

*require